Doctors in the United States will soon be advised not to describe paracetamols for pregnant women

Medical experts, including Steven Fleischman, president of the American College of Gynecologists, rejected the statements, saying there is no solid scientific evidence linking the use of acetaminophein (paracetamol) to child development problems. Paracetamoli remains the safest drug for pregnancy according to medical groups and world governments, the BBC writes.

The producer of Tylenol, Kenvoue, stressed that science shows no link between acetaminophein and autism, warning of the dangers of limiting safe options to alleviate pain.

Trump made the announcement in the Oval Office along with Health Secretary Robert F. Kennedy Jr., who said that the FDA will provide guidelines for doctors and review the drug label. Kennedy also announced that the FDA would approve the use of leukemia for children with autism based on early studies showing benefits in improving verbal communication.

In August, a review of the dean-led research of Chan School of Public Health, Harvard University, found that children may be more inclined to develop autism and other neurodevelopive disorders when exposed to Tylenol during pregnancy. Researchers suggested that some steps be taken to limit the use of the medicine, but said it remains important for the treatment of temperature and pain in mothers, which may also have negative effects on children.

However, researchers warn that the research is in early stages and has no clear conclusions. Other studies have shown that using paracetamol during pregnancy is not safely linked to autism, ADHD or intellectual disability.

The diagnosis of autism has increased since 2000, with a rate of 2.77 percent among eight-year-old children in 2020 (CDC). Scientists partly attribute increased awareness and expansion to the definition of disorder. Kennedy previously promoted controversial theories, blaming vaccines, without evidence.